Royal Bank of Canada upgraded shares of Elevance Health (NYSE:ELV – Get Rating) from a sector perform rating to an outperform rating in a research report released on Tuesday, Marketbeat Ratings reports. Royal Bank of Canada currently has $572.00 price target on the stock, up from their prior price target of $523.00. ELV has been […]
Elevance Health (NYSE:ELV – Get Rating) had its price objective lowered by stock analysts at Truist Financial from $610.00 to $580.00 in a research note issued on Friday, The Fly reports. Truist Financial’s price target points to a potential upside of 30.09% from the company’s current price. ELV has been the topic of several other […]